ST 198 is an orally active D3R antagonist. ST 198 can block the expression of nicotine-induced CPP at doses selective for D3R. ST 198 can be used for the research of neurological disease[1].
Molecular Weight:
334.45
CAS Number:
[854924-64-4]
Formula:
C22H26N2O
Target:
Dopamine Receptor
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted